Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine

Open access
Zhang, Kai, Sakamoto, Akemi, Chang, Lijia, Qu, Youge, Wang, Siming, Pu, Yaoyu, Tan, Yunfei, Wang, Xingming, Fujita, Yuko, Ishima, Tamaki, Hatano, Masahiko, Hashimoto, Kenji · 2021 · European Archives of Psychiatry and Clinical Neuroscience

Abstract

The spleen is a large immune organ that plays a key role in the immune system. The precise molecular mechanisms underlying the relationship between the spleen and stress-related psychiatric disorders are unknown. Here we investigated the role of spleen in stress-related psychiatric disorders. FACS analysis was applied to determine the contribution of the spleen to susceptibility and resilience in mice that were subjected to chronic social defeat stress (CSDS). We found a notable increase in splenic volume and weight in CSDS-susceptible mice compared to control (no CSDS) mice and CSDS-resilient mice. The number of granulocytes, but not of T cells and B cells, in the spleen of susceptible mice was higher than in the spleen of both control and resilient mice. Interestingly, NKG2D (natural killer group 2, member D) expression in the spleen of CSDS-susceptible mice was higher than that in control mice and CSDS-resilient mice. In addition, NKG2D expression in the spleen of patients with depression was higher than that in controls. Both increased splenic weight and increased splenic NKG2D expression in CSDS-susceptible mice were ameliorated after a subsequent administration of (R)-ketamine. The present findings indicate a novel role of splenic NKG2D in stress susceptibility versus resilience in mice subjected to CSDS. Furthermore, abnormalities in splenic functions in CSDS-susceptible mice were ameliorated after subsequent injection of (R)-ketamine. Thus, the brain–spleen axis might, at least in part, contribute to the pathogenesis of stress-related psychiatric disorders such as depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00406-019-01092-z

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schedule of CSDS and FACS analysis. a The schedule of chronic social defeat stress (CSDS) model, social interaction test, and collection of spleen. CSDS was performed for 10 days (day 1- day 10). On day 11, the social interaction test was performed to separate CSDS-susceptible mice and CSDS-resilient mice. Control (no CSDS) mice were used as control group. On day 12, spleen from the three groups was collected. b Representative picture of spleen from control (no CSDS) mice, CSDS-susceptible mice, and CSDS-resilient mice. Spleen weight of CSDS-susceptible mice was significantly higher than that of control mice and CSDS-resilient mice (one-way ANOVA, F2,21 = 437.136, P < 0.001). c Total cell number of spleen (one-way ANOVA, F2,21 = 6.616, P = 0.006). d T cells: The number of TCR+ cells in the spleen (one-way ANOVA, F2,21 = 0.032, P = 0.968). e B cells: The number of B220+ in the spleen (one-way ANOVA, F2,21 = 1.429, P = 0.262). f Granulocyte: The number of Gr1+ cells in the spleen (one-way ANOVA, F2,21 = 14.958, P < 0.001). g A positive correlation (r = 0.845, P < 0.001) between Gr1+ cells (for granulocytes) and spleen weight among three groups. Data are shown as mean ± SEM. (n = 8). **P < 0.01, ***P < 0.001 ANOVA analysis of variance, B220 B cells, Gr1 granulocyte receptor 1, CD11b a marker of macrophages, N.S. not significant, TCR T cell receptor
Fig. 1 Schedule of CSDS and FACS analysis. a The schedule of chronic social defeat stress (CSDS) model, social interaction test, and collection of spleen. CSDS was performed for 10 days (day 1- day 10). On day 11, the social interaction test was performed to separate CSDS-susceptible mice and CSDS-resilient mice. Control (no CSDS) mice were used as control group. On day 12, spleen from the three groups was collected. b Representative picture of spleen from control (no CSDS) mice, CSDS-susceptible mice, and CSDS-resilient mice. Spleen weight of CSDS-susceptible mice was significantly higher than that of control mice and CSDS-resilient mice (one-way ANOVA, F2,21 = 437.136, P < 0.001). c Total cell number of spleen (one-way ANOVA, F2,21 = 6.616, P = 0.006). d T cells: The number of TCR+ cells in the spleen (one-way ANOVA, F2,21 = 0.032, P = 0.968). e B cells: The number of B220+ in the spleen (one-way ANOVA, F2,21 = 1.429, P = 0.262). f Granulocyte: The number of Gr1+ cells in the spleen (one-way ANOVA, F2,21 = 14.958, P < 0.001). g A positive correlation (r = 0.845, P < 0.001) between Gr1+ cells (for granulocytes) and spleen weight among three groups. Data are shown as mean ± SEM. (n = 8). **P < 0.01, ***P < 0.001 ANOVA analysis of variance, B220 B cells, Gr1 granulocyte receptor 1, CD11b a marker of macrophages, N.S. not significant, TCR T cell receptorCC BY · PubMed Central
Fig. 2 Behavioral tests and NKG2D expression in the spleen of CSDS-susceptible mice and CSDS-resilient mice. a The schedule of CSDS model, social interaction test, behavioral tests, and collection of spleen. CSDS was performed for 10 days (day 1–day 10). On day 11, the social interaction test was performed to separate CSDS-susceptible mice and CSDS-resilient mice. On day 12, locomotion and TST were performed. On day 13, FST was performed. On day 14, SPT was performed. On day 15, spleen from the three groups was collected. Control (no CSDS) mice were used as control group. b Locomotion (one-way ANOVA, F2,21 = 0.118, P = 0.889). c TST (one-way ANOVA, F2,21 = 8.494, P = 0.002). d FST (one-way ANOVA, F2,21 = 13.317, P < 0.001). e SPT (one-way ANOVA, F2,21 = 5.395, P = 0.013). f NKG2D expression in the spleen (one-way ANOVA, F2,21 = 4.278, P = 0.028). g A positive correlation (r = 0.767, P < 0.001) between TST immobility time and NKG2D expression in the spleen. h A positive correlation (r = 0.929, P < 0.001) between FST immobility time and NKG2D expression in the spleen. Data are shown as mean ± SEM. (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001. ANOVA analysis of variance, FST forced swimming test, N.S. not significant, SPT sucrose preference test, TST tail suspension test
Fig. 2 Behavioral tests and NKG2D expression in the spleen of CSDS-susceptible mice and CSDS-resilient mice. a The schedule of CSDS model, social interaction test, behavioral tests, and collection of spleen. CSDS was performed for 10 days (day 1–day 10). On day 11, the social interaction test was performed to separate CSDS-susceptible mice and CSDS-resilient mice. On day 12, locomotion and TST were performed. On day 13, FST was performed. On day 14, SPT was performed. On day 15, spleen from the three groups was collected. Control (no CSDS) mice were used as control group. b Locomotion (one-way ANOVA, F2,21 = 0.118, P = 0.889). c TST (one-way ANOVA, F2,21 = 8.494, P = 0.002). d FST (one-way ANOVA, F2,21 = 13.317, P < 0.001). e SPT (one-way ANOVA, F2,21 = 5.395, P = 0.013). f NKG2D expression in the spleen (one-way ANOVA, F2,21 = 4.278, P = 0.028). g A positive correlation (r = 0.767, P < 0.001) between TST immobility time and NKG2D expression in the spleen. h A positive correlation (r = 0.929, P < 0.001) between FST immobility time and NKG2D expression in the spleen. Data are shown as mean ± SEM. (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001. ANOVA analysis of variance, FST forced swimming test, N.S. not significant, SPT sucrose preference test, TST tail suspension testCC BY · PubMed Central
Fig. 3 Protein expression of NKG2D in the parietal cortex and spleen from patients with major psychiatric disorders. a Parietal cortex: There were no changes (one-way ANOVA, F3,53 = 3.004, P = 0.051) among the four groups. The bands of representative bands of Western blot analysis were shown. Data are shown as mean ± SEM. (n = 15). b Spleen: There were significant changes (one-way ANOVA, F3,52 = 2.673, P = 0.048) among the four groups. Expression of NKG2D in the spleen of MDD patients was significantly (P = 0.012) higher than controls. *P < 0.05. Data are shown as mean ± SEM. (n = 12–15). The bands of representative bands of Western blot analysis were shown. CON control, MDD major depressive disorder, SZ schizophrenia, BD bipolar disorder, N.S. not significant
Fig. 3 Protein expression of NKG2D in the parietal cortex and spleen from patients with major psychiatric disorders. a Parietal cortex: There were no changes (one-way ANOVA, F3,53 = 3.004, P = 0.051) among the four groups. The bands of representative bands of Western blot analysis were shown. Data are shown as mean ± SEM. (n = 15). b Spleen: There were significant changes (one-way ANOVA, F3,52 = 2.673, P = 0.048) among the four groups. Expression of NKG2D in the spleen of MDD patients was significantly (P = 0.012) higher than controls. *P < 0.05. Data are shown as mean ± SEM. (n = 12–15). The bands of representative bands of Western blot analysis were shown. CON control, MDD major depressive disorder, SZ schizophrenia, BD bipolar disorder, N.S. not significantCC BY · PubMed Central
Fig. 4 Effects of (R)-ketamine on depression-like phenotypes, abnormal splenic functions in the CSDS-susceptible mice. a The schedule of CSDS model, social interaction test, treatment, behavioral tests, and collection of spleen. CSDS was performed for 10 days (day 1–day 10). On day 11, the social interaction test was performed to select CSDS-susceptible mice. Control (no CSDS) mice were used as control group. On day 12, saline (10 ml/kg) or (R)-ketamine (10 mg/kg) was administered i.p. into CSDS-susceptible mice. Saline was administered i.p. into control (no CSDS) mice. Locomotion and TST were performed 1 and 3 h after injection, respectively. On day 13, FST was performed. On day 14, SPT was performed. On day 15, spleen from the three groups was collected. b Locomotion (one-way ANOVA, F2,15 = 0.270, P = 0.767). c TST (one-way ANOVA, F2,15 = 5.188, P = 0.019). d FST (one-way ANOVA, F2,15 = 4.446, P = 0.030). e SPT (one-way ANOVA, F2,15 = 6.376, P = 0.010). f Representative picture of spleen from saline-treated control (no CSDS) mice, saline-treated CSDS-susceptible mice, and (R)-ketamine-treated CSDS-susceptible mice. Spleen weight of (R)-ketamine-treated CSDS-susceptible mice was significantly lower higher than that of saline-treated CSDS-resilient mice (one-way ANOVA, F2,15 = 12.052, P = 0.001). g Western blot analysis of NKG2D expression in the spleen (one-way ANOVA, F2,15 = 7.591, P = 0.005). The representative bands of Western blot analysis were shown. Data are shown as mean ± SEM. (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001. ANOVA analysis of variance, ANOVA analysis of variance, FST forced swimming test, NKG2D natural-killer receptor group 2, member D, N.S. not significant, SPT sucrose preference test, TST tail suspension test
Fig. 4 Effects of (R)-ketamine on depression-like phenotypes, abnormal splenic functions in the CSDS-susceptible mice. a The schedule of CSDS model, social interaction test, treatment, behavioral tests, and collection of spleen. CSDS was performed for 10 days (day 1–day 10). On day 11, the social interaction test was performed to select CSDS-susceptible mice. Control (no CSDS) mice were used as control group. On day 12, saline (10 ml/kg) or (R)-ketamine (10 mg/kg) was administered i.p. into CSDS-susceptible mice. Saline was administered i.p. into control (no CSDS) mice. Locomotion and TST were performed 1 and 3 h after injection, respectively. On day 13, FST was performed. On day 14, SPT was performed. On day 15, spleen from the three groups was collected. b Locomotion (one-way ANOVA, F2,15 = 0.270, P = 0.767). c TST (one-way ANOVA, F2,15 = 5.188, P = 0.019). d FST (one-way ANOVA, F2,15 = 4.446, P = 0.030). e SPT (one-way ANOVA, F2,15 = 6.376, P = 0.010). f Representative picture of spleen from saline-treated control (no CSDS) mice, saline-treated CSDS-susceptible mice, and (R)-ketamine-treated CSDS-susceptible mice. Spleen weight of (R)-ketamine-treated CSDS-susceptible mice was significantly lower higher than that of saline-treated CSDS-resilient mice (one-way ANOVA, F2,15 = 12.052, P = 0.001). g Western blot analysis of NKG2D expression in the spleen (one-way ANOVA, F2,15 = 7.591, P = 0.005). The representative bands of Western blot analysis were shown. Data are shown as mean ± SEM. (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001. ANOVA analysis of variance, ANOVA analysis of variance, FST forced swimming test, NKG2D natural-killer receptor group 2, member D, N.S. not significant, SPT sucrose preference test, TST tail suspension testCC BY · PubMed Central
Fig. 5 FACS analysis of spleen samples of three groups. a Total cell number of spleen (one-way ANOVA, F2,15 = 4.659, P = 0.027). b The number of NKG2D+ cells in the spleen (one-way ANOVA, F2,15 = 5.207, P = 0.019). Data are shown as mean ± SEM. (n = 6). *P < 0.05, **P < 0.01. c FACS analysis of cells stained with antibodies against NKG2D and DX5 in spleen samples from saline-treated control mice, saline-treated CSDS-susceptible mice, and (R)-ketamine-treated CSDS-susceptible mice. (R)-ketamine ameliorated the increased percentage of NKG2D+ cells in the spleen of CSDS-susceptible mice. ANOVA analysis of variance, DX5 CD49b, NKG2D natural-killer receptor group 2, member D
Fig. 5 FACS analysis of spleen samples of three groups. a Total cell number of spleen (one-way ANOVA, F2,15 = 4.659, P = 0.027). b The number of NKG2D+ cells in the spleen (one-way ANOVA, F2,15 = 5.207, P = 0.019). Data are shown as mean ± SEM. (n = 6). *P < 0.05, **P < 0.01. c FACS analysis of cells stained with antibodies against NKG2D and DX5 in spleen samples from saline-treated control mice, saline-treated CSDS-susceptible mice, and (R)-ketamine-treated CSDS-susceptible mice. (R)-ketamine ameliorated the increased percentage of NKG2D+ cells in the spleen of CSDS-susceptible mice. ANOVA analysis of variance, DX5 CD49b, NKG2D natural-killer receptor group 2, member DCC BY · PubMed Central
Fig. 6 Proposed mechanisms of the role of brain–spleen axis in the stress-induced psychiatric disorders. Stress caused increase of spleen size and weight, resulting in abnormalities in spleen functions. Brain inflammation by stress might be mediated by brain–spleen axis (i.e., vagus nerve). NKG2D in spleen may play a role in the stress-related psychiatric disorders such as depression. Interestingly, (R)-ketamine ameliorates abnormalities of spleen functions and depressive symptoms by stress
Fig. 6 Proposed mechanisms of the role of brain–spleen axis in the stress-induced psychiatric disorders. Stress caused increase of spleen size and weight, resulting in abnormalities in spleen functions. Brain inflammation by stress might be mediated by brain–spleen axis (i.e., vagus nerve). NKG2D in spleen may play a role in the stress-related psychiatric disorders such as depression. Interestingly, (R)-ketamine ameliorates abnormalities of spleen functions and depressive symptoms by stressCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 64

Metadata

Authors
Zhang, K., Sakamoto, A., Chang, L., Qu, Y., Wang, S., Pu, Y., Tan, Y., Wang, X., Fujita, Y., Ishima, T., Hatano, M., & Hashimoto, K.
Affiliations
Chiba University (JP)
Corresponding author
Hashimoto, Kenji
Venue
European Archives of Psychiatry and Clinical Neuroscience
Published
2019-12-24
Volume
271
Issue
3
Pages
447-456
ISSN
  • 0003-9373 (ISSN-L)
  • 0940-1334
  • 1433-8491
OpenAlex
W2997792045
Cited by
63
References
54
Citations by year
2026: 7 · 2025: 8 · 2024: 11 · 2023: 6 · 2022: 16 · 2021: 8 · 2020: 6
FWCI
4.90
Type
journal article
Language
en
Open access
Licence
Locations
  • European Archives of Psychiatry and Clinical Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Japan Agency for Medical Research and Development (JP19dm0107119)
  • Japan Society for the Promotion of Science (19K17054)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
NKG2D, spleen, chronic social defeat stress, stress vulnerability, resilience, (R)-ketamine, depression, spleen weight, stress-related psychiatric disorders
MeSH terms
Social Defeat, Animals, Antidepressive Agents, Autopsy, Behavior, Animal, Major Depressive Disorder, Disease Models, Animal, Disease Susceptibility, Humans, Ketamine, Mice, Inbred C57BL, Parietal Lobe, Spleen, Stress, Psychological, Mice, Resilience, Psychological, NK Cell Lectin-Like Receptor Subfamily K

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine. https://app.cochat.ai/papers/10.1007/s00406-019-01092-z
The paper
Zhang, K., Sakamoto, A., Chang, L., Qu, Y., Wang, S., Pu, Y., Tan, Y., Wang, X., Fujita, Y., Ishima, T., Hatano, M., & Hashimoto, K. (2021). Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-019-01092-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.